Dr. Columbus’ research group focuses on the architecture and motions of membrane proteins from pathogenic bacteria, with the aim of understanding how the proteins enable bacteria to hijack normal human cellular function. The long-term application of her research is to utilize the new mechanistic understanding of function in order to develop targeted therapeutic delivery systems. In addition to the applications to human health, her laboratory also develops methods for investigating these difficult systems.